The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical and genomic analysis of metastatic disease progression in a background of biochemical recurrence.
Anamaria Crisan
Employment or Leadership Position - GenomeDx Biosciences
Mercedeh Ghadessi
Employment or Leadership Position - GenomeDx Biosciences
Christine Buerki
Employment or Leadership Position - GenomeDx Biosciences
Ismael A. Vergara
Employment or Leadership Position - GenomeDx Biosciences
Darby J. S. Thompson
Consultant or Advisory Role - GenomeDx Biosciences
Nicholas Erho
Employment or Leadership Position - GenomeDx Biosciences
Thomas Sierocinski
Employment or Leadership Position - GenomeDx Biosciences
Zaid Haddad
Employment or Leadership Position - GenomeDx Biosciences
Benedikt Zimmermann
Employment or Leadership Position - GenomeDx Biosciences
Worlanyo Sosu-Sedzorme
Employment or Leadership Position - GenomeDx Biosciences
Sebastian Harko
Employment or Leadership Position - GenomeDx Biosciences
Peter C. Black
Consultant or Advisory Role - GenomeDx Biosciences
Research Funding - GenomeDx Biosciences
Elai Davicioni
Employment or Leadership Position - GenomeDx Biosciences
Robert B. Jenkins
Research Funding - GenomeDx Biosciences